LON:CIR Circassia Group (CIR) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Circassia Group Stock (LON:CIR) Get Circassia Group alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume4,513 shsAverage Volume773,465 shsMarket Capitalization£142.66 millionP/E Ratio3,400.00Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Circassia Group Plc, a medical device company, focuses on the respiratory diagnostics and monitoring products in the United States, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It offers NIOX and NIOX VERO, a fractional exhaled nitric oxide measurement and monitoring products for use in asthma diagnosis and management. The company offers its products approximately in 50 countries through a network of distribution partners. The company was formerly known as Circassia Pharmaceuticals plc and changed its name to Circassia Group Plc in May 2020. Circassia Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom. Read More Receive CIR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Circassia Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CIR Stock News HeadlinesCIRCOR to Expand Industrial Portfolio with Acquisition of Green Silence Group S.p.A.October 30, 2026 | businesswire.comParker Hannifin Buys Circor Aerospace Business for $2.5 BillionMay 21, 2026 | barrons.comYour father's savings lost half their value after 1971.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.November 20 at 1:00 AM | Reagan Gold Group (Ad)Parker-Hannifin Strikes $2.5 Billion Deal for Unit of KKR-Owned CircorMay 21, 2026 | wsj.comPrivate equity firm withdraws takeover bid for NIOX GroupApril 11, 2025 | msn.comNiox Group PLC (NIOX)April 10, 2025 | uk.investing.comGlobal Respiratory Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsightAugust 8, 2024 | finance.yahoo.comAllergy Shot Market Revenue Estimated to Grow at 6.1% CAGR to Reach US$ 3.34 Billion by 2034: Fact.MR ReportJuly 19, 2024 | finance.yahoo.comSee More Headlines CIR Stock Analysis - Frequently Asked Questions How were Circassia Group's earnings last quarter? Circassia Group Plc (LON:CIR) announced its quarterly earnings results on Thursday, September, 17th. The company reported GBX (3) earnings per share for the quarter. What other stocks do shareholders of Circassia Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Circassia Group investors own include AstraZeneca (AZN), boohoo group (BOO), Touchstone Innovations (IVO), Oxford Biomedica (OXB), Vectura Group (VEC), Agios Pharmaceuticals (AGIO) and Ageas (AGESY). Industry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolLON:CIR CIKN/A Webwww.circassia.co.uk Phone44 1865 405 560FaxN/AEmployees111Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio3,400.00 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio1.95 Current Ratio1.83 Quick Ratio1.50 Sales & Book Value Annual Sales£27.90 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow11.33 Book ValueGBX 16 per share Price / BookN/AMiscellaneous Outstanding Shares419,578,000Free FloatN/AMarket Cap£142.66 million OptionableNot Optionable BetaN/A 7 Blue-Chip Stocks to Add To Your Forever PortfolioA strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership. This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.Get This Free Report This page (LON:CIR) was last updated on 9/2/2022 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredWorse than socialismDonald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same ec...Porter & Company | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredA Bill Would Reprice America's Gold at Market ValueThe US government still values its gold at $42 an ounce, a price Congress set in 1973. Gold trades above $4,00...Concord Gold Capital | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Circassia Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Circassia Group With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.